These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9640345)

  • 1. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.
    Webb NJ; Bottomley MJ; Watson CJ; Brenchley PE
    Clin Sci (Lond); 1998 Apr; 94(4):395-404. PubMed ID: 9640345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.
    Möhle R; Green D; Moore MA; Nachman RL; Rafii S
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):663-8. PubMed ID: 9012841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
    Werther K; Christensen IJ; Nielsen HJ
    Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM; Blann AD; Lip GY
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
    Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
    Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release of vascular endothelial growth factor during platelet aggregation.
    Maloney JP; Silliman CC; Ambruso DR; Wang J; Tuder RM; Voelkel NF
    Am J Physiol; 1998 Sep; 275(3):H1054-61. PubMed ID: 9724313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood.
    Gunsilius E; Petzer A; Stockhammer G; Nussbaumer W; Schumacher P; Clausen J; Gastl G
    Oncology; 2000 Feb; 58(2):169-74. PubMed ID: 10705245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of platelets in VEGF-mediated angiogenesis in tumors.
    Salgado R; Benoy I; Dirix L; Vermeulen P; Van Marck E
    FEBS Lett; 2002 Jun; 520(1-3):182. PubMed ID: 12044894
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
    Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
    Banks RE; Forbes MA; Kinsey SE; Stanley A; Ingham E; Walters C; Selby PJ
    Br J Cancer; 1998 Mar; 77(6):956-64. PubMed ID: 9528841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients.
    Bortoloso E; Del Prete D; Gambaro G; Dalla Vestra M; Sailer A; Baggio B; Antonucci F; Fioretto P; Anglani F
    Ren Fail; 2001; 23(3-4):483-93. PubMed ID: 11499563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
    Christou H; Yoshida A; Arthur V; Morita T; Kourembanas S
    Am J Respir Cell Mol Biol; 1998 Jun; 18(6):768-76. PubMed ID: 9618381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome.
    Hashiguchi T; Arimura K; Matsumuro K; Otsuka R; Watanabe O; Jonosono M; Maruyama Y; Maruyama I; Osame M
    Muscle Nerve; 2000 Jul; 23(7):1051-6. PubMed ID: 10882999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma.
    Fakhari M; Pullirsch D; Paya K; Abraham D; Hofbauer R; Aharinejad S
    J Pediatr Surg; 2002 Apr; 37(4):582-7. PubMed ID: 11912515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.
    Roeckl W; Hecht D; Sztajer H; Waltenberger J; Yayon A; Weich HA
    Exp Cell Res; 1998 May; 241(1):161-70. PubMed ID: 9633524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.